Clinical Trial Update: Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating afamelanotide with narrow-band UVB phototherapy for nonsegmental vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Afamelanotide (afamelanotide)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Vitiligo | Phase 1 | Status: COMPLETED